Topamax
Product Images NDC 54868-5190

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topamax (NDC 54868-5190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

The packaging label for Topamax (topiramate) by Physicians Total Care, Inc. shows a 25 mg strength in a bottle containing 30 tablets. The label includes the NDC number 54868-4672-1, dosage form, caution against dispensing without prescription, dosage instructions, storage conditions, lot number 46029, and expiration date 01/20.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Topamax 100 mg tablet bottle label distributed by Physicians Total Care, Inc. The label shows the NDC number 54868-4674-2, a quantity of 60 tablets, lot number and expiration date (01/60), and the manufacturer listed as Jensen Ortho, LLC, Colorado.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Topamax 200 mg tablet bottle label by Physicians Total Care, Inc. The label shows the proprietary name Topamax with the active ingredient topiramate, strength of 200 mg, and a bottle count of 30 tablets. It includes cautions about prescription dispensing, storage instructions, and manufacturer details.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Topamax 50 mg tablets packaging label from Physicians Total Care, Inc. The label states the product name, strength, and dosage form, with a count of 30 tablets per bottle. The label highlights that each tablet contains 50 mg of the active ingredient topiramate. Additional regulatory and dispensing information is present, including a caution against dispensing without prescription and storage instructions. Barcodes and lot number/expiration details are also visible.*

FDA Label Image

Chemical Structure (Topamax 01)

Chemical structure diagram of the active ingredient in Topamax, depicting the molecular arrangement including multiple oxygen atoms, methyl groups, and a sulfonamide functional group.*

FDA Label Image

Figure 1 (Topamax 02)

A line graph depicting the cumulative rate for time to first seizure for Topiramate at 50 mg/day and 400 mg/day doses over a period of up to 500 days. The graph shows two lines representing different dose groups with an associated p-value (0.0002) indicating statistical comparison between them.*

FDA Label Image

Figure 2 (Topamax 03)

A bar chart comparing changes from baseline to double-blind phase in average monthly migraine period rate (±SE) for placebo and Topamax at 50 mg/day, 100 mg/day, and 200 mg/day dosages. The chart shows data from two studies labeled TOPMAT-MIGR-001 and TOPMAT-MIGR-002, with significance noted for 100 mg/day and 200 mg/day dosages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.